Talk:Main Page
From eplmediawiki
Revision as of 10:48, 15 August 2014 by 37.187.142.194 (Talk)
A few months <a href=" http://eventosvippass.com/gala/ ">celexa 10mg reviews kw</a> "These events provide clarity to Rigel's pipeline. We now have a clear picture of the Phase III program for fostamatinib in ITP and we plan to start the studies early next year," said Rigel CEO James Gower. "Unfortunately, discoid lupus is a difficult indication and R333 didn't provide the benefit we had hoped. However, this frees up resources to focus on our ITP and dry eye programs."
